STI: Clinical Trials

3 trials for STI, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 43Completed 3

Follow STI: new trials by email Literature Review of STI trials Research Report on STI

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Weekly Doxycycline DOT for STI Prevention Among Cisgender Women Taking HIV PrEP in Kisumu, Kenya
Doxycycline - STI
Phase 4CompletedUniversity of Washington602024-08-132026-04-13
Parrying the Pitfalls of PrEP: Project PEACH
PrEP discontinuation intervention, Offering of on-demand oral PrEP, Offering of STI PEP - HIV, STI
Phase 4CompletedEmory University2402021-11-202026-04-01
PrEParing Family Planning Clinics to Streamline Integration of HIV Prevention Services for Young Women in Kenya
PrEP - HIV Infections, Contraception
Phase 4CompletedUniversity of Washington254572021-03-012025-09-04

Narrower conditions

Sexually Transmitted Diseases (3)  ·  HIV Infections (1)

Broader conditions

Communicable Diseases (3)  ·  Disease Attributes (3)  ·  Genital Diseases (3)  ·  Infections (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Urogenital Diseases (3)  ·  Blood-Borne Infections (1)  ·  Immune System Diseases (1)  ·  Immunologic Deficiency Syndromes (1)  ·  Lentivirus Infections (1)  ·  RNA Virus Infections (1)  ·  Retroviridae Infections (1)  ·  Sexually Transmitted Diseases, Viral (1)  ·  Virus Diseases (1)

Interventions

Doxycycline (2)  ·  Emtricitabine (1)  ·  Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1)  ·  Tenofovir (1)  ·  cabotegravir (1)

Sponsors

University of Washington (2)  ·  Emory University (1)

Countries

Kenya (2)  ·  United States (1)

Top investigators

Elizabeth Bukusi, PhD, MPH (1)  ·  Kenneth Mugwanya, MBChB, MS, PhD (1)  ·  Patrick Sullivan, MD (1)

Results publications

PMID 34895357, PMID 40267471, PMID 41802176, PMID 42232582, PMID 42850961

NIH funding

R01AI145971 (1), R01MH123267 (1), R01MH123724 (1)